 However, as ChIP-on-chip technology advances, high resolution whole mammalian genome maps should become achievable.Antibodies used for ChIP-on-chip can be an important limiting factor.ChIP-on-chip requires highly specific antibodies that must recognize its epitope in free solution and also under fixed conditions.